Jacob Gottlieb and Stuart Weisbrod are both big names when it comes to investing in the world of health care. The 2 have collaborated in the past and have announced that they have plans to join forces once again in the near future. Currently, the 2 even share the same office space in New York City and previously worked together at Merlin BioMed Group.
Currently, Jacob Gottlieb is heading his investment firm known as Altium Capital. While the New York City-based fund may still be in its early stages, they are already getting a good amount of attention on Wall Street with their investment choices. The investor earned his MD at the New York University and it has been an integral part in his choices as a health care investor.
While Jacob Gottlieb may be busy with his company, he is also bust with philanthropy efforts. Not only has he donated his money from his past ventures and Altium to organizations around New York City, but he has also given his time and effort to them. While his efforts and assets have gone to different organizations who offer financial assistance for the vulnerable in society around the city, he especially cares about education. He credits the excellent education that he received as one of the main factors in his successful career. He cares about preparing children for life by providing them with the educational opportunities that they need.
One of the investments that Jacob Gottlieb has made with Altium already is out of Dublin and known as Amarin. The company also has offices in New Jersey and focuses on medication for cardiovascular problems. The benefits from the medication are from polyunsaturated fatty acids which have potential therapeutic uses. One of their medication was approved in 2012 by the Food and Drug Administration.